Author
Listed:
- Yasuhiro Yamaguchi
(Department of Pulmonary Medicine, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan)
- K.M. Saif-Ur-Rahman
(Department of Public Health and Health Systems, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan
Health Systems and Population Studies Division, ICDDR,B, Dhaka 1212, Bangladesh)
- Motoko Nomura
(Department of Pulmonary Medicine, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan)
- Hiromitsu Ohta
(Department of Pulmonary Medicine, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan)
- Yoshihisa Hirakawa
(Department of Public Health and Health Systems, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan)
- Takashi Yamanaka
(Department of Home Care Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan)
- Satoshi Hirahara
(Tokyo Fureai Medical Co-op Research & Education Center, Tokyo 114-0004, Japan)
- Hisayuki Miura
(Department of Home Care and Regional Liaison Promotion, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan)
Abstract
A previous pooled analysis demonstrated significant relief of breathlessness following opioid administration in patients with chronic obstructive pulmonary disease. However, in clinical practice, it is important to know the characteristics of patients responding to opioids, the best prescription methods, and the evaluation measures that can sufficiently reflect these effects. Thus, we performed a systematic review of systemic opioids for non-cancer chronic respiratory diseases. Fifteen randomized controlled studies (RCTs), four non-randomized studies, two observational studies, and five retrospective studies were included. Recent RCTs suggested that regular oral opioid use would decrease the worst breathlessness in patients with a modified Medical Research Council score ≥ 3 by a degree of 1.0 or less on a scale of 1–10. Ergometer or treadmill tests indicated mostly consistent significant acute effects of morphine or codeine. In two non-randomized studies, about 60% of patients responded to opioids and showed definite improvement in symptoms and quality of life. Furthermore, titration of opioids in these studies suggested that a major proportion of these responders had benefits after administration of approximately 10 mg/day of morphine. However, more studies are needed to clarify the prescription method to reduce withdrawal due to adverse effects, which would lead to significant improvements in overall well-being.
Suggested Citation
Yasuhiro Yamaguchi & K.M. Saif-Ur-Rahman & Motoko Nomura & Hiromitsu Ohta & Yoshihisa Hirakawa & Takashi Yamanaka & Satoshi Hirahara & Hisayuki Miura, 2022.
"Opioid Prescription Method for Breathlessness Due to Non-Cancer Chronic Respiratory Diseases: A Systematic Review,"
IJERPH, MDPI, vol. 19(8), pages 1-16, April.
Handle:
RePEc:gam:jijerp:v:19:y:2022:i:8:p:4907-:d:796190
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:8:p:4907-:d:796190. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.